23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
This edition of Orrick’s series of life sciences publications reviews fullyear 2020 data in depth t...
Read More >
When outside forces pose a threat to people’s livelihood, people will go to great lengths to fight ...
Read More >
Almost all long-haul drivers are exempt from overtime under the motor carrier exemption to the Fair ...
Read More >
Today we share our conversation with Haley Altman, founder and CEO of Doxly, which was recently acqu...
Read More >
Refinancing activity has proven an attractive option amid COVID-19 disruption, with borrowers in goo...
Read More >
Labor Board Further Tightens Union Access To Employer Property - In yet another ruling that levels...
Read More >